CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more
CeriBell, Inc (CBLL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.069x
Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.069x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-10.77 Million) by net assets ($155.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CeriBell, Inc - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shanghai Kelai Mechatronics
SHG:603960
|
0.027x |
|
Chongqing Lummy Pharmaceutical
SHE:300006
|
-0.008x |
|
Fulgent Sun International Holding Co Ltd
TW:9802
|
0.142x |
|
Georgia Capital PLC
PINK:GRGCF
|
0.016x |
|
Karnov Group AB
ST:KAR
|
0.023x |
|
Zhejiang Meili High Technology Co Ltd
SHE:300611
|
0.064x |
|
Meridianlink Inc
NYSE:MLNK
|
0.049x |
|
BeiJing Certificate Authority Co Ltd
SHE:300579
|
-0.073x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |